The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hospital Acquired Infections (HAI) Diagnostics Market Research Report 2025

Global Hospital Acquired Infections (HAI) Diagnostics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1713696

No of Pages : 64

Synopsis

Market Analysis and Insights: Global Hospital Acquired Infections (HAI) Diagnostics Market

Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections.

The global Hospital Acquired Infections (HAI) Diagnostics market size is projected to reach US$ 4474.4 million by 2028, from US$ 3331.9 million in 2021, at a CAGR of 4.3% during 2022-2028.

The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric population base. Advancing age of the geriatric population makes them more vulnerable and prone to diseases, thus increasing the demand for diagnosis.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hospital Acquired Infections (HAI) Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hospital Acquired Infections (HAI) Diagnostics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hospital Acquired Infections (HAI) Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hospital Acquired Infections (HAI) Diagnostics market.

Global Hospital Acquired Infections (HAI) Diagnostics Scope and Market Size
Hospital Acquired Infections (HAI) Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Infections (HAI) Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Molecular Diagnostics Tests
  • Other In-vitro Diagnostic Tests

Segment by Application

  • Bloodstream Infections (BSI)
  • Urinary Tract Infections (UTI)
  • Surgical Site Infections (SSI)
  • Pneumonia
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Biomérieux
  • Abbott Laboratories
  • Roche Ag
  • Siemens Healthcare
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Molecular Diagnostics Tests
1.2.3 Other In-vitro Diagnostic Tests
1.3 Market by Application
1.3.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Bloodstream Infections (BSI)
1.3.3 Urinary Tract Infections (UTI)
1.3.4 Surgical Site Infections (SSI)
1.3.5 Pneumonia
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Perspective (2017-2028)
2.2 Hospital Acquired Infections (HAI) Diagnostics Growth Trends by Region
2.2.1 Hospital Acquired Infections (HAI) Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Hospital Acquired Infections (HAI) Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Hospital Acquired Infections (HAI) Diagnostics Market Dynamics
2.3.1 Hospital Acquired Infections (HAI) Diagnostics Industry Trends
2.3.2 Hospital Acquired Infections (HAI) Diagnostics Market Drivers
2.3.3 Hospital Acquired Infections (HAI) Diagnostics Market Challenges
2.3.4 Hospital Acquired Infections (HAI) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Revenue
3.1.1 Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital Acquired Infections (HAI) Diagnostics Revenue
3.4 Global Hospital Acquired Infections (HAI) Diagnostics Market Concentration Ratio
3.4.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infections (HAI) Diagnostics Revenue in 2021
3.5 Hospital Acquired Infections (HAI) Diagnostics Key Players Head office and Area Served
3.6 Key Players Hospital Acquired Infections (HAI) Diagnostics Product Solution and Service
3.7 Date of Enter into Hospital Acquired Infections (HAI) Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Acquired Infections (HAI) Diagnostics Breakdown Data by Type
4.1 Global Hospital Acquired Infections (HAI) Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Type (2023-2028)
5 Hospital Acquired Infections (HAI) Diagnostics Breakdown Data by Application
5.1 Global Hospital Acquired Infections (HAI) Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Hospital Acquired Infections (HAI) Diagnostics Market Size (2017-2028)
6.2 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2017-2022)
6.3 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size (2017-2028)
7.2 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2017-2022)
7.3 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2017-2022)
8.3 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size (2017-2028)
9.2 Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2017-2022)
9.3 Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2017-2022)
10.3 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 BioMérieux
11.1.1 BioMérieux Company Detail
11.1.2 BioMérieux Business Overview
11.1.3 BioMérieux Hospital Acquired Infections (HAI) Diagnostics Introduction
11.1.4 BioMérieux Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2017-2022)
11.1.5 BioMérieux Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Introduction
11.2.4 Abbott Laboratories Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2017-2022)
11.2.5 Abbott Laboratories Recent Development
11.3 Roche AG
11.3.1 Roche AG Company Detail
11.3.2 Roche AG Business Overview
11.3.3 Roche AG Hospital Acquired Infections (HAI) Diagnostics Introduction
11.3.4 Roche AG Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2017-2022)
11.3.5 Roche AG Recent Development
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Detail
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Introduction
11.4.4 Siemens Healthcare Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2017-2022)
11.4.5 Siemens Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Molecular Diagnostics Tests
Table 3. Key Players of Other In-vitro Diagnostic Tests
Table 4. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Region (2017-2022)
Table 8. Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Region (2023-2028)
Table 10. Hospital Acquired Infections (HAI) Diagnostics Market Trends
Table 11. Hospital Acquired Infections (HAI) Diagnostics Market Drivers
Table 12. Hospital Acquired Infections (HAI) Diagnostics Market Challenges
Table 13. Hospital Acquired Infections (HAI) Diagnostics Market Restraints
Table 14. Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Players (2017-2022)
Table 16. Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Acquired Infections (HAI) Diagnostics as of 2021)
Table 17. Ranking of Global Top Hospital Acquired Infections (HAI) Diagnostics Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Hospital Acquired Infections (HAI) Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hospital Acquired Infections (HAI) Diagnostics Product Solution and Service
Table 21. Date of Enter into Hospital Acquired Infections (HAI) Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Type (2017-2022)
Table 25. Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Type (2023-2028)
Table 27. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Application (2017-2022)
Table 29. Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Application (2023-2028)
Table 31. North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 41. BioMérieux Company Detail
Table 42. BioMérieux Business Overview
Table 43. BioMérieux Hospital Acquired Infections (HAI) Diagnostics Product
Table 44. BioMérieux Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2017-2022) & (US$ Million)
Table 45. BioMérieux Recent Development
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Product
Table 49. Abbott Laboratories Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2017-2022) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Roche AG Company Detail
Table 52. Roche AG Business Overview
Table 53. Roche AG Hospital Acquired Infections (HAI) Diagnostics Product
Table 54. Roche AG Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2017-2022) & (US$ Million)
Table 55. Roche AG Recent Development
Table 56. Siemens Healthcare Company Detail
Table 57. Siemens Healthcare Business Overview
Table 58. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Product
Table 59. Siemens Healthcare Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2017-2022) & (US$ Million)
Table 60. Siemens Healthcare Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. Molecular Diagnostics Tests Features
Figure 3. Other In-vitro Diagnostic Tests Features
Figure 4. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Application in 2021 & 2028
Figure 5. Bloodstream Infections (BSI) Case Studies
Figure 6. Urinary Tract Infections (UTI) Case Studies
Figure 7. Surgical Site Infections (SSI) Case Studies
Figure 8. Pneumonia Case Studies
Figure 9. Others Case Studies
Figure 10. Hospital Acquired Infections (HAI) Diagnostics Report Years Considered
Figure 11. Global Hospital Acquired Infections (HAI) Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Hospital Acquired Infections (HAI) Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Region: 2021 VS 2028
Figure 14. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Players in 2021
Figure 15. Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Acquired Infections (HAI) Diagnostics as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Hospital Acquired Infections (HAI) Diagnostics Revenue in 2021
Figure 17. North America Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Hospital Acquired Infections (HAI) Diagnostics Market Share by Country (2017-2028)
Figure 19. United States Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Hospital Acquired Infections (HAI) Diagnostics Market Share by Country (2017-2028)
Figure 23. Germany Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Share by Region (2017-2028)
Figure 31. China Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Hospital Acquired Infections (HAI) Diagnostics Market Share by Country (2017-2028)
Figure 39. Mexico Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Share by Country (2017-2028)
Figure 43. Turkey Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. BioMérieux Revenue Growth Rate in Hospital Acquired Infections (HAI) Diagnostics Business (2017-2022)
Figure 46. Abbott Laboratories Revenue Growth Rate in Hospital Acquired Infections (HAI) Diagnostics Business (2017-2022)
Figure 47. Roche AG Revenue Growth Rate in Hospital Acquired Infections (HAI) Diagnostics Business (2017-2022)
Figure 48. Siemens Healthcare Revenue Growth Rate in Hospital Acquired Infections (HAI) Diagnostics Business (2017-2022)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’